SOURCE: MedLink International, Inc.

January 24, 2007 15:46 ET

MedLink International to Present at the Friedland Investment Micro-Cap Conference

ISLANDIA, NY -- (MARKET WIRE) -- January 24, 2007 -- MedLink International, Inc. (OTCBB: MLKNA) (FRANKFURT: WM6B), a leading provider of Health Information Technology to physicians and the medical community, today announced that it will be presenting at the Friedland Investment Micro-Cap Conference at the Doubletree Metropolitan Hotel in New York City.

Ray Vuono, Chief Executive Officer, and Jameson Rose, Chief Financial Officer, will be presenting an overview of the company as well as its growth strategies on Thursday, January 25th, 2007 at 10:00 am ET.

For more information about the event, or to register to attend, please visit

About MedLink International, Inc.:

The business of MedLink International, Inc. (OTCBB: MLKNA) (FRANKFURT: WM6B) is carried out through its flagship product, the MedLink VPN in conjunction with its proprietary MedLink EHR software. The MedLink Virtual Private Network allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-rays, CAT scans and other Personal Health Information (PHI). The MedLink VPN incorporates several third-party applications and the company has developed a state-of-the-art Healthcare IT infrastructure on the MedLink VPN. The company also offers other products and services such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, video conferencing and Optical Memory Cards for personal health records (PHR). The company has developed unique partnerships in the medical community and it utilizes those partnerships to market its products and services. The company website is

Note on Forward-Looking Statements:

Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on current expectations and are subject to a number of known and unknown risks, uncertainties and other factors beyond our control that could cause actual events and results to differ materially from these statements. These statements are not guarantees of future performance, and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. MedLink International, Inc. undertakes no obligation to update publicly any forward-looking statements.

Contact Information